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Abstract Hepatocellular carcinoma (HCC) is the ¢fth most
common cancer in the world. We constructed subtracted
cDNA libraries enriched with genes overexpressed in HCCs.
Among the 17 genes identi¢ed were molecular chaperones,
Hsp110, Hsp90B, and Hsp70-1. Expression of the Hsp110 fam-
ily members was further analyzed, and increased transcript lev-
els of Hsp110 and Apg-2, but not Apg-1, were found in 12 and
14, respectively, of 18 HCCs. Immunohistochemical analysis
demonstrated the overexpression of the proteins in tumor cells.
Apg-2 had chaperone ability similar to Hsp110 in a thermal
denaturation assay using luciferase, and showed anti-apoptotic
activity. These results suggest that the Hsp110 family members
play important roles in hepatocarcinogenesis through their chap-
eroning activities.
/ 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Key words: Hepatocellular carcinoma; Hsp70; Hsp110;
Apg-2; Apg-1; Chaperone
1. Introduction
Hepatocellular carcinoma (HCC) is one of the most com-
mon cancers in Asia and Africa, where hepatitis virus infec-
tions and exposure to speci¢c liver carcinogens are prevalent
[1,2]. Although screening of high risk populations by ultra-
sonography and measurement of the serum K-fetoprotein level
has facilitated the early detection of HCC, the overall survival
of patients with HCC is unsatisfactory. Several studies have
identi¢ed alterations of several genes, but the molecular mech-
anisms of hepatocarcinogenesis have not been fully elucidated
[1,2]. It is, therefore, important to identify molecules that can
be used as diagnostic or prognostic markers and molecular
targets to develop novel preventive or therapeutic agents.
A number of conditions that are damaging to cellular pro-
teins can trigger the increased expression of several highly
conserved proteins that are referred to as heat shock proteins
(Hsps)[3,4]. Hsps not only protect cells from the toxic e¡ects
of heat and other stresses, but also have multiple housekeep-
ing functions, such as folding and translocating newly synthe-
sized proteins, activation of speci¢c regulatory proteins, pro-
tein degradation, protein signaling and antigen presentation.
Additionally, Hsps can inhibit the irreversible aggregation of
denatured proteins and, in some instances, function in the
refolding of denatured proteins. The major classes of mam-
malian Hsps include Hsp110s, Hsp90s, Hsp70s, Hsp60s,
Hsp40s and the small Hsps [5].
Hsp110 cDNAs were initially cloned from Chinese hamster
and mouse (often called Hsp105) [6,7]. Subsequently, we have
isolated Hsp110-related genes, Apg (ATP and peptide-binding
protein in germ cells)-1/Osp94 and Apg-2, and demonstrated
that the human as well as mouse Hsp110 family consisted of
Apg-1, Apg-2 and Hsp110 [8^10]. Constitutive expression of
Apg-1 is mainly observed in the testis, while expression of
Hsp110 and Apg-2 is observed in various organs [11].
Hsp110 has been identi¢ed as one of the genes induced by
the human papilloma virus oncoprotein E7 [12]. Of the three
members of the Hsp110 family, expression of Hsp110 and
Apg-1, but not Apg-2 is inducible by heat stress in mouse
and human cells [8,10]. In contrast, expression of all Hsp110
family members is induced after transient forebrain ischemia
in rats [13]. Collectively, these observations suggest that the
expression of each Hsp110 family member is independently
regulated and inducible under various conditions including
oncogenic stress.
By constructing subtracted cDNA libraries enriched with
the genes overexpressed in HCCs, we have previously reported
identi¢cation of the novel proteins gankyrin and HSCO
[14,15]. Gankyrin is overexpressed in most HCCs and accel-
erates the degradation of the retinoblastoma gene product
(Rb). HSCO shows anti-apoptotic activity and enhances nu-
clear export of NF-UB. In this study, we used the remaining
cDNA clones as probes in Northern blot analysis, and iden-
ti¢ed 17 genes overexpressed in HCCs including three molec-
ular chaperones. We further examined expression of all mem-
bers of the Hsp110 family in HCCs, and determined the
molecular chaperoning activity of Apg-2 in vitro and in vivo.
2. Materials and methods
2.1. Surgical specimens
Primary HCCs and corresponding non-malignant liver tissue were
obtained from 18 patients undergoing surgical resection at the Kyoto
University Hospital, Japan. Informed consent was obtained from each
patient. The stage of tumor progression was determined by serum
tumor marker, CT scan, chest X-ray and pathological analysis. The
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age of the patients was 62.1O 8.5 years (meanOS.D.). Twelve were
males and six were females. There were three, six, seven and two
patients with stage I, II, III and IV HCCs, respectively. The degree
of tumor cell di¡erentiation was assessed according to the classi¢ca-
tion of Edmondson and Steiner. Six patients were positive for the
hepatitis B surface antigen and/or antibody to it, and 11 were positive
for the anti-hepatitis C antibody. The relationship between Hsp110 or
Apg-2 expression and clinicopathological status was analyzed by Fish-
er’s exact probability two-tailed test using the JMP software (SAS
Institute, Cary, NC, USA).
2.2. Cell culture
Human 293T cells, mouse NIH/3T3 cells, monkey COS7 cells and
their transfectants were maintained in Dulbecco’s modi¢ed Eagle’s
medium supplemented with 10% fetal calf serum at 37‡C, 5% CO2
in air. Transfection and isolation of stable clones were performed as
described [14]. NIH/3T3 Tet-On gankyrin cells were made by co-trans-
fection of NIH/3T3 cells with pTet-On plasmid and pTRE2 plasmid
(Clontech, Tokyo, Japan) containing gankyrin cDNA, followed by
selection of clones inducibly overexpressing gankyrin. The numbers
of viable cells were counted by the trypan blue exclusion method using
a hemocytometer under a microscope.
2.3. Construction of subtracted cDNA libraries
Isolation of RNA and the cDNA subtraction were performed es-
sentially as described previously [14,16]. Total RNA was extracted
from two stage IV HCCs and their corresponding non-malignant
tissues. After synthesizing double-stranded cDNAs, we constructed
subtracted cDNA libraries by using our original method [16] or
with the PCR Select Subtraction kit (Clontech, Palo Alto, CA,
USA) following the manufacturer’s protocol.
2.4. Antibodies
Polyclonal antibodies were raised by immunizing rabbits with glu-
tathione S-transferase fusion proteins of the mouse Apg-1 or Apg-2
corresponding to amino acids 96^582 or 60^841, respectively. A poly-
clonal anti-Hsp110 antibody was a kind gift from Dr. H. Itoh, Akita
University [17]. A⁄nity-puri¢ed immunoglobulin (Ig) derived from
preimmune rabbit sera was used as a negative control. Mouse mono-
clonal anti-hemagglutinin (HA) antibody (Boehringer Mannheim Bio-
chemica, Mannheim, Germany), anti-His antibody (Clontech), anti-
gankyrin antibody [14] and horseradish peroxidase-conjugated goat
anti-rabbit Ig (Bio-Rad, Hercules, CA, USA) were diluted in phos-
phate-bu¡ered saline (PBS) containing 5% bovine serum albumin to
the appropriate concentrations.
2.5. Analysis of gene expression
Northern and Western blot analyses were performed as described
[15]. Speci¢city of the cDNA probe used for each Hsp110 family
member has been veri¢ed [10]. The band intensities were compared
between the HCC and non-cancerous tissues from the same patient
after normalization. To determine the speci¢city of antibodies,
cDNAs containing full coding regions for human Hsp110, Apg-1
and Apg-2 were cloned into pCAGGS vector with HA tags
(pCMV-3HA). 293T cells were transfected with these plasmids or
vector alone to express Hsp110 family members N-terminally tagged
with HA or HA alone, respectively, and cell lysates were subjected to
Western blotting.
Immunohistochemistry was performed as described [15] using sec-
tions from the tissues ¢xed in 4% paraformaldehyde in PBS and
embedded in wax. Peroxidase-conjugated anti-rabbit IgG and diami-
nobenzidine were used to visualize the bound antibodies. As a control,
the preimmune serum was used at the same dilution.
2.6. Chaperone activities
Apg-2 cDNA was cloned into pQE9 vector (Qiagen, Tokyo, Japan),
and chaperone activities were assayed as previously described [18].
Brie£y, 50 nM luciferase (Sigma Aldrich, Tokyo, Japan) was equili-
brated to room temperature with ovalbumin or recombinant Apg-2,
followed by incubation at 43‡C in a thermostated cuvette. Light scat-
tering by protein aggregation was determined by measuring the in-
crease in optical density at 320 nm with a spectrophotometer. For
luciferase reactivation experiments, luciferase (150 nM) was incubated
with ovalbumin or recombinant Apg-2 at 43‡C for 30 min and diluted
to 15 nM in 60% rabbit reticulocyte lysate (Promega) at 30‡C. For the
measurement of luciferase activity, the reactivation solution was ¢ve-
fold diluted, and added to luciferase assay solution (Promega). The
activity was measured with a Lumat LB 9501 luminometer (Berthold).
In vivo chaperoning activity of Apg-2 was examined by co-trans-
fecting COS7 cells with plasmids expressing mutant HSCO fused with
green £uorescent protein (GFP) (H. Higashitsuji, unpublished obser-
vation) and plasmids expressing Apg-2, Hsp70 or vector alone.
Fig. 1. Increased expression of genes isolated from hepatoma-derived subtracted cDNA libraries in HCCs. Ten Wg of total RNA from pairs of
non-cancerous liver tissue (N) and HCC (T) were subjected to Northern blot analysis using 32P-labeled hepatoma-derived subtracted cDNA
clones (HSCC3 to HSCC19) as probes as indicated. cDNA for 18S ribosomal RNA (rRNA) was used as a control. Mobilities of 18S and/or
28S rRNAs are indicated on the left. Case numbers are shown at the top.
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Thirty-six hours after transfection, the percentage of cells with cyto-
plasmic aggregates in GFP-positive cells was determined with a con-
focal laser microscope (Olympus, Tokyo, Japan). The percentage of
apoptotic cells was also assessed by determining the percentage of
cells with sub-G1 DNA content by £ow cytometry after staining
with propidium iodide.
3. Results
3.1. Identi¢cation of genes overexpressed in HCCs
After analyzing the subtracted cDNA libraries enriched
with genes overexpressed in HCCs compared with non-cancer-
ous liver tissues, we identi¢ed 17 distinct cDNA clones in
addition to those of HSCO and gankyrin previously reported
[14,15]. Their expression was increased in at least two out of
seven HCCs analyzed by Northern blotting (Fig. 1). A homol-
ogy search with BLAST software revealed that all cDNAs
corresponded to known genes including Hsp110, Hsp90B
and Hsp70-1 (Table 1).
3.2. Increased expression of Hsp110 family members in HCCs
Since the human Hsp110 family consists of Hsp110, Apg-1
and Apg-2 [10], we further examined expression of Apg-1 and
Apg-2 as well as Hsp110 in a total of 18 HCCs. The transcript
level of Hsp110 was increased in 12 of 18 HCCs (Figs. 1 and
2). The transcript level of Apg-2 was increased in 14 of 18
HCCs (Fig. 2). All 12 HCCs overexpressing Hsp110 also over-
expressed Apg-2. In contrast, no expression of Apg-1 was
detected in HCCs or the non-cancerous liver tissues (data
not shown). The relationship between the overexpression of
Hsp110 or Apg-2 and the clinicopathological ¢ndings was
examined, but no signi¢cant association with virus infection
status, K-fetoprotein level, histologic grade, portal involve-
ment, number of tumors, or clinical stage was identi¢ed
(data not shown).
Human papilloma virus oncoprotein E7 is known to induce
Hsp110 [12]. Since gankyrin, which is commonly overex-
pressed in HCCs, has activities similar to E7 [14], we inves-
tigated the possibility that gankyrin might induce expression
of Hsp110 or Apg-2. When gankyrin was overexpressed in
NIH/3T3 cells, the levels of Hsp110 and Apg-2 transcripts
were not increased, suggesting that gankyrin is not related
to the overexpression of Hsp110 and Apg-2 (data not shown).
3.3. Increased expression of Hsp110 and Apg-2 proteins in
HCCs
We next examined the protein levels of Hsp110 and Apg-2
in HCCs. Since the amino acid sequences of Hsp110, Apg-1
and Apg-2 are quite similar to each other and between mice
and humans, we ¢rst determined the speci¢city of polyclonal
antibodies raised against the respective mouse proteins. As
shown in Fig. 3, the mobilities of HA-tagged Hsp110 and
HA-tagged Apg-2 were slower than that of HA-tagged Apg-
1. The anti-Hsp110 antibody recognized Hsp110 and Apg-1.
The anti-Apg-1 antibody recognized Apg-1, but not Apg-2 or
Hsp110. The anti-Apg-2 antibody speci¢cally recognized Apg-
2. Since no expression of Apg-1 was detected in HCCs by
Northern blot analysis, the anti-Hsp110 antibody was used
to determine the protein level of Hsp110. In three pairs of
Table 1
Identity of clones isolated by subtractive hybridization
Clone Identity (accession number) Function
HSCC1a HSCO (hepatoma subtracted cDNA clone one) (D83198) anti-apoptosis
HSCC2a Gankyrin (PSMD10, p28) (D83197) increased degradation of Rb
HSCC3 Heat shock 105/110 kDa protein 1 (HSPH1, HSP105B, HSP110) (NM_006644) chaperone
HSCC4 Ribosomal protein L14 (RPL14) (NM_003973) translation
HSCC5 Ribosomal protein S17 (RPS17) (NM_001021) translation
HSCC6 Ribosomal protein S15a (RPS15A) (NM_001019) translation
HSCC7 Apolipoprotein A2 (APOA2) (NM_001643) lipid metabolism
HSCC8 Cathepsin F (CTSF) (NM_003793) lysosomal cysteine protease
HSCC9 ADP-ribosylation factor-like 6 interacting protein-1 (Aip-1) (XM_027365) unknown, binding to ARL-6 in yeast
HSCC10 Hypothetical protein MGC2668 (NM_030914) unknown, ubiquitin-related modi¢er-like
HSCC11 Fatty acid coenzyme A ligase, long-chain 5 (FACL5) (NM_016234) fatty acid metabolism
HSCC12 Pancreatitis-associated protein (PAP, PAP1, HIP) (NM_002580) C-type lectin
HSCC13 Ferritin, light polypeptide (FTL) (NM_000146) iron storage
HSCC14 Elongation factor 1-K1 (EEF1A1) (NM_001402) translation
HSCC15 Plasmalemma vesicle-associated protein (PLVAP, PV-1) (NM_031310) endothelial membrane protein
HSCC16 KIAA1274 (AB033100) unknown, PTPase catalytic domain-like
HSCC17 SPARC-like 1 protein (SPARCL1, mast9, hevin) (NM_004684) anti-adhesive extracellular matrix protein
HSCC18 Heat shock 90 kDa protein 1, L (HSPCB, HSP90B, HSPC2) (NM_007355) chaperone
HSCC19 Heat shock 70 kDa protein 1A (HSPA1A, HSP70-1) (NM_005345) chaperone
aPreviously reported [14,15].
Fig. 2. Increased transcript levels of the Hsp110 family members in
HCCs. Ten Wg of total RNA from pairs of non-cancerous liver tis-
sues (N) and HCCs (T) were subjected to Northern blot analysis us-
ing cDNA for Hsp110 or Apg-2 as probes as indicated. cDNA for
18S ribosomal RNA (rRNA) was used as a control. Mobilities of
18S and 28S rRNAs are indicated on the left. Case numbers are
shown at the top.
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HCC specimens analyzed, both Hsp110 and Apg-2 protein
levels were increased in HCCs compared with the non-cancer-
ous tissues (Fig. 3E,F), and the results were consistent with
those of the Northern blot analysis.
To identify the cells overexpressing Hsp110 and Apg-2 in
HCC tissues, we performed an immunohistochemical analysis
(Fig. 4). Speci¢c signals for Hsp110 and Apg-2 were observed
in the cytoplasm of HCC cells, but not in the adjacent non-
cancerous cells, demonstrating that the expression of Hsp110
and Apg-2 proteins was increased in cancer cells.
3.4. Chaperoning activity of Apg-2
The chaperoning activities of Hsp110 and Apg-1 have been
demonstrated [17,18]. To determine whether Apg-2 has equiv-
alent chaperoning activity, we used luciferase as a reporter in
basic holding and folding assays. As shown in Fig. 5A, Apg-2
was e⁄cient in inhibiting the heat-induced aggregation of lu-
ciferase in vitro. When Apg-2 was present during heating at a
1:1 molar ratio with luciferase, the enzyme remained highly
soluble.
When the activity of luciferase heated in the presence of
Apg-2 was measured, however, no original activity was ob-
served nor was activity restored during further incubation of
the complex (data not shown). To determine whether Apg-2
requires the cooperation of other Hsps and/or chaperones to
refold denatured substrate proteins, we heated luciferase in
the presence of Apg-2 or ovalbumin, and then added the
proteins to a 60% rabbit reticulocyte lysate that has been
shown to be an optimal refolding medium [18]. As shown in
Fig. 5B, luciferase heated in the presence of Apg-2 regained
46% of the original activity, whereas luciferase heated with
ovalbumin did not. These results demonstrate that Apg-2 is
a potent chaperone in inhibiting aggregation and maintaining
Fig. 3. Increased protein levels of Hsp110 and Apg-2 in HCCs.
A^D: Speci¢city of the antibodies. Cell lysates from 293T cells
transfected with plasmids expressing HA alone (lanes 1), and
Hsp110 (lanes 2), Apg-1 (lanes 3) or Apg-2 (lanes 4) N-terminally
tagged with HA were Western-blotted and probed with a monoclo-
nal mouse anti-HA antibody (A), polyclonal rabbit anti-Hsp110
antibody (B), anti-Apg-1 antibody (C) or anti-Apg-2 antibody (D).
Asterisks indicate non-speci¢c bands. E,F: Overexpression of
Hsp110 and Apg-2 proteins. Total extracts from three pairs of non-
cancerous liver tissues (N) and HCCs (T) were Western-blotted and
probed with the indicated antibodies. Arrowheads indicate the mo-
bilities of the speci¢c proteins.
Fig. 4. Immunohistochemical analysis of expression patterns of
Hsp110 and Apg-2 in HCCs. Tissue sections were made from HCC
(A^C) and non-cancerous liver tissue (D^F). Immunohistochemical
staining was performed using an anti-Hsp110 antibody (A,D), anti-
Apg-2 antibody (B,E) or preimmune serum (C,F). Note, top areas
of panels A^C are non-cancerous tissues and are not stained with
either the anti-Hsp110 or anti-Apg-2 antibody. Bar, 50 Wm.
Fig. 5. Chaperone activity of Apg-2. A: E¡ects on protein aggrega-
tion in vitro. Heat-induced aggregation of luciferase in the presence
or absence of Apg-2 was assayed by light scattering. Ovalbumin
(OVA) was used as a control protein. Molar ratios to luciferase are
indicated in parentheses. The values are expressed as percentage of
the aggregation observed when luciferase alone (NON) was incuba-
ted for 30 min at 43‡C. B: E¡ects on protein refolding in vitro. Lu-
ciferase was heated for 30 min at 43‡C in the presence of a 20-fold
molar excess of Apg-2 or OVA. The proteins were then added to
60% rabbit reticulocyte lysate, allowed to refold at 30‡C for the in-
dicated times, and the luciferase activity was measured as described
[18]. C: E¡ects on aggregation of mutant proteins in vivo. COS7
cells were transfected with plasmids expressing wild-type HSCO or
mutant HSCO fused with GFP (HSCOwt and HSCOmut, respec-
tively) and observed under a £uorescence microscope (left). COS7
cells were co-transfected with HSCOmut plasmids and plasmids ex-
pressing Hsp70, Apg-2, or vector alone as indicated, and the per-
centage of cells with cytoplasmic aggregates in GFP-positive cells
was determined (right). *P6 0.05 vs. vector alone.
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a folding-competent state but is incapable of refolding heat-
denatured proteins on its own.
To determine the chaperoning activity of Apg-2 in vivo, we
utilized mutant HSCO which forms cytoplasmic aggregates
and induces apoptosis when expressed in COS7 cells (H. Hi-
gashitsuji, unpublished observation). As shown in Fig. 5C,
expression of Apg-2 signi¢cantly reduced the formation of
aggregates. At the same time, the percentage of cells with
sub-G1 DNA content was reduced compared with control
(21.2 O 1.9% vs. 27.6O 1.9%, P6 0.05).
4. Discussion
One approach to understand the molecular mechanisms of
carcinogenesis, progression and drug resistance is to compare
gene expression between tumor tissues and normal tissues. By
using microarrays, Okabe et al. [19] have analyzed expression
patterns of 24 030 genes in 20 HCCs, and suggested that ex-
pression of speci¢c genes could be associated with the viral
etiology of the tumor, vascular invasion and other features.
Chen et al. [20] have analyzed 17 400 genes in 82 HCCs, and
found 1640 genes to be up- or down-regulated. Recently, Chu-
ma et al. [21] have found that Hsp70 is a marker of early
HCCs. In this and our previous studies [14,15], we have uti-
lized the cDNA subtraction method followed by Northern
blotting, and identi¢ed 19 genes overexpressed in HCCs. In-
terestingly, two of them were novel genes and six have not
been identi¢ed to be overexpressed in HCCs by the micro-
array technique [19^25].
Hsps have been suggested to play roles in tumorigenesis as
modi¢ers of protein activities, in particular, components of
the cell cycle machinery, kinases, and other proteins impli-
cated in cancer progression [4,26]. Overexpression of Hsp70
has been correlated with advanced stages, poor prognosis or
resistance to therapy in breast cancers, endometrial cervix
cancers and HCCs [21,26,27]. However, in osteosarcomas,
the overexpression of Hsp70 has been associated with re-
sponse to chemotherapy [28]. Overexpression of Hsp27 has
been correlated with high histologic grade and poor prognosis
in HCCs, but with improved prognosis in others [27,29].
These inconsistent ¢ndings suggest that Hsps may have a
pivotal function in cell proliferation depending on tumor
type. In HCCs, we found that transcripts for Hsp110 family
members, Hsp110 and Apg-2, were overexpressed in 67% and
78%, respectively, of HCC tissues, and that the tumor cells
expressed these proteins. Although Hsp110 functionally inter-
acts with Hsc70 and Hsp27 [30] which are prognostic indica-
tors in some cancer types, the increased expression of Hsp110
and Apg-2 did not correlate with any clinical ¢ndings.
Molecular chaperones induced in response to stress appear
to function at key regulatory points in the control of cell
survival. For example, overexpression of Hsp70 protects tu-
mor cells from a variety of stresses [26]. Hsp110 as well as
Hsp70 confers thermal tolerance to cells [18]. The protective
function of the Hsps may be extended to include an anti-ap-
optotic role for several members of the Hsp family including
Hsp90, Hsp70 and Hsp27 [26,31]. Furthermore, chaperones
have been shown to repair the conformational defects of
some mutated proteins, thus reducing their phenotypic e¡ects
[32]. In this study, we demonstrated the in vitro chaperoning
activity of Apg-2, and showed that Apg-2 decreases aggregate
formation and apoptosis induced by mutant HSCO proteins.
Since evasion of apoptosis is one of the hallmarks of the
cancer cell phenotype, Hsp110 family members probably con-
tribute to hepatocarcinogenesis by acting as molecular chap-
erones in cooperation with other Hsps to inhibit apoptotic
pathways induced by mutant proteins. Further studies on
the functions of Hsp110 and Apg-2 in HCCs, and develop-
ment of techniques to modulate the expression levels of these
proteins will provide a novel targeted approach to control
HCC cell proliferation.
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